journal cover

Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study

Blood

Nov 14, 2019

Carlo ViscoMarco Ruggeri

Get paper from

Abstract

Immune thrombocytopenia (ITP) secondary to chronic lymphoproliferative disorders (LPDs) is poorly responsive to conventional treatments. We conducted a multicenter phase 2 prospective 24-week study in 18 patients with ITP secondary to LPDs to assess the safety and efficacy of eltrombopa...read more

Mentioned in this Paper

Blood Platelets
Complete Excision
Hemorrhage
Hodgkin Disease
Immunization
Chronic Lymphocytic Leukemia
Lymphoproliferative Disorders
Waldenstrom Macroglobulinemia
Cytotoxicity Assay
Autoimmune Thrombocytopenia
2
1
4
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study

Blood

Nov 14, 2019

Carlo ViscoMarco Ruggeri

PMID: 31570488

DOI: 10.1182/blood.2019001617

Abstract

Immune thrombocytopenia (ITP) secondary to chronic lymphoproliferative disorders (LPDs) is poorly responsive to conventional treatments. We conducted a multicenter phase 2 prospective 24-week study in 18 patients with ITP secondary to LPDs to assess the safety and efficacy of eltrombopa...read more

Mentioned in this Paper

Blood Platelets
Complete Excision
Hemorrhage
Hodgkin Disease
Immunization
2
1
4

Related Papers

Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Get paper from

/papers/eltrombopag-for-immune-thrombocytopenia-secondary/31570488